Rare diseases
Investigational molecules
Locations
328 conditions with trials, the busiest first
865 trials across Europe, recruiting first
Study of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor
AustriaStudy of Palbociclib with Drug Combinations for Children and Young Adults with Recurrent or Refractory Neuroblastoma and Ewing Sarcoma
CzechiaStudy on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy
BelgiumStudy on the Use of Fludeoxyglucose (18F) in PET/CT Scans for Young Patients with Histiocytosis
PolandStudy on Trametinib Dimethyl Sulfoxide for Children with Refractory Histiocytosis Not Responding to Conventional Treatment
PolandStudy on Vemurafenib for Children with BRAF Mutation-Resistant Histiocytosis
PolandStudy on the Effectiveness of Botulinum Toxin Type A for Patients with Cervical Dystonia and Abnormal Muscle Activity
FinlandStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
AustriaStudy on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus
The NetherlandsStudy Comparing Diclofenac and Thiocolchicoside Injection to Diclofenac Alone for Patients with Acute Moderate to Severe Low Back Pain
GreeceStudy on the Safety and Effectiveness of BOOST Cells for Treating Severe Osteogenesis Imperfecta in Children Before and After Birth
The NetherlandsStudy on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma
FranceThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
